Psoriasis drugs may weaken bones, new study reveals
NCT ID NCT07140666
First seen Oct 31, 2025 · Last updated May 22, 2026 · Updated 30 times
Summary
This study looked at 100 adults with moderate-to-severe psoriasis to see how two common biologic drugs (Secukinumab and Adalimumab) affect bone density. Psoriasis is a long-term inflammatory condition that can raise the risk of weak bones. The goal was to understand if these treatments help or harm bone health over time. Results may guide safer treatment choices for patients at risk of bone loss.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Chinese PLA General Hosptial
Beijing, Beijing Municipality, 100853, China
Conditions
Explore the condition pages connected to this study.